Insulin resistance and type 2 diabetes in children

키워드

참고문헌 (93)

1. Reaven GM, "Insulin resistance : the link between obesity and cardiovascular disease", Endocrinol Metab Clin North Am, 37, pp.581~601 (2008)
2. Razani B, "Insulin resistance and atherosclerosis", Endocrinol Metab Clin North Am, 37, pp.603~621 (2008)
3. Chiarelli F, "Insulin resistance and obesity in childhood", Eur J Endocrinol, 159, pp.67~74 (2008)
4. Volovelsky O, "Fatty liver disease in obese children relation to other metabolic risk factors", Int J Pediatric Obes, 6, pp.59~64 (2011)
5. Levy-Marchal C, "Insulin resistance in children : consensus, perspective, and future directions", J Clin Endocrinol Metabol, 95, pp.5189~5198 (2010)
6. Ferrannini E, "Insulin resistance is central to the burden of diabetes", Diab Metab Rev, 13, pp.81~86 (1997)
7. Giannini C, "Islet function in obese adolescents", Diab Obes Metabo, 14, pp.40~45 (2012)
8. Lawrence JM, "Trends in incidence of type 1 diabetes among non-Hispanic white youth in the U.S., 2002–2009", Diabetes, 63, pp.3938~3945 (2014)
9. Dabelea D, "Prevalence of type 1and type 2 diabetes among children and adolescents from 2001 to 2009", JAMA, 311, pp.1778~1786 (2014)
10. Liu LL, "Prevalence of overweight and obesity in youth with diabetes in USA : the SEARCH for Diabetes in Youth study", Pediatr Diabetes, 11, pp.4~11 (2010)
11. Candler TP, "Continuing rise of type 2 diabetes incidence in children and young people in the UK", Diabet Med, 35, pp.737~744 (2018)
12. Schober E, "Austrian Diabetes Incidence Study Group : incidence and time trend of type 1 and type 2 diabetes in Austrian children 1999-2007", J Pediatr, 155, pp.190~193 (2009)
13. 이정현, "Incidence trends and associated factors of diabetes mellitus in Korean children and adolescents: a retrospective cohort study in Busan and Gyeongnam", Annals of Pediatric Endocrinology & Metabolism, 20(4), pp.206~212 (2015), 대한소아내분비학회
14. Ye Q, "Paediatric type 2 diabetes in China-Pandemic, progression, and potential solutions", Pediatr Diabetes, 19, pp.27~35 (2018)
15. Sjardin N, "Increasing incidence of type 2 diabetes in New Zealand children <15 years of age in a regional-based diabetes service, Auckland, New Zealand", J Paediatr Child Health, 54, pp.1005~1010 (2018)
16. Imperatore G, "Projections of type 1 and type 2 diabetes burden in the U.S. population aged, 20 years through 2050:dynamic modeling of incidence, mortality, and population growth", Diabetes Care, 35, pp.2515~2520 (2012)
17. Pettitt DJ, "Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study", Diabetes Care, 37, pp.402~408 (2014)
18. Amed S, "Type 2 diabetes, medication induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study", Diabetes Care, 33, pp.786~791 (2010)
19. Haines L, "Rising incidence of type 2 diabetes in children in the U. K", Diabetes Care, 30, pp.1097~1101 (2007)
20. Pavkov ME, "Changing patterns of type 2diabetes incidence among Pima Indians", Diabetes Care, 30, pp.1758~1763 (2007)
21. Arslanian S, "Evaluation and management of youth-onset type 2 diabetes : a position statement by the American Diabetes Association", Diabetes Care, 41, pp.2648~2668 (2018)
22. Zeitler P, "A clinical trial to maintain glycemic control in youth with type 2 diabetes", N Engl J Med, 366, pp.2247~2256 (2012)
23. Todd JN, "Advances in the genetics of youth-onset type 2 diabetes", Curr Diab Rep, 18, pp.57~ (2018)
24. Ashcroft FM, "Diabetes mellitus and the beta cell : the last ten years", Cell, 148, pp.1160~1171 (2012)
25. Dupuis J, "New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk", Nat Genet, 42, pp.105~116 (2010)
26. Barker A, "Association of genetic Loci with glucose levels in childhood and adolescence:a metaanalysis of over 6,000 children", Diabetes, 60, pp.1805~1812 (2011)
27. Giannini C, "Co-occurrence of risk alleles in or near genes modulating insulin secretion predisposes obese youth to prediabetes", Diabetes Care, 37, pp.475~482 (2014)
28. Cropano C, "The rs7903146 variant in the TCF7L2gene increases the risk of prediabetes", type 2 diabetes in obese adolescents by impairing β-cell function and hepatic insulin sensitivity, 2017, pp.40, 1082~1089
29. Kahn SE, "Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function", Diabetes, 42, pp.1663~1672 (1993)
30. Bacha F, "From pre-diabetes to type 2 diabetes in obese youth : pathophysiological characteristics along the spectrum of glucose dysregulation", Diabetes Care, 33, pp.2225~2231 (2010)
31. Bacha F, "In vivo insulin sensitivity and secretion in obese youth : what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes", Diabetes Care, 32, pp.100~105 (2009)
32. Giannini C, "Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths : a longitudinal study", Diabetes, 61, pp.606~614 (2012)
33. Cnop M, "Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes : many differences, few similarities", Diabetes, 54, pp.S97~107 (2005)
34. Lenzen S, "Oxidative stress : the vulnerable beta-cell", Biochem Soc Trans, 36, pp.343~347 (2008)
35. Arslanian SA, "Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth", Diabetes Care, 28, pp.115~119 (2005)
36. Ball GD, "Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty", J Pediatr, 148, pp.16~22 (2006)
37. Copeland KC, "Characteristics of adolescents and youth with recent-onset type 2 diabetes : the TODAY cohort at baseline", J Clin Endocrinol Metab, 96, pp.159~167 (2011)
38. Chernausek SD, "Relationship between parental diabetes and presentation of metabolic and glycemic function in youth with type 2 diabetes: baseline findings from the TODAY trial", Diabetes Care, 39, pp.110~117 (2016)
39. Dabelea D, "Association of intrauterine exposure to maternal diabetes and obesity with type 2diabetes in youth : the SEARCH Case-Control Study", Diabetes Care, 31, pp.1422~1426 (2008)
40. American Diabetes Association, "Children and adolescent : standards of medical care in Diabetes-2020", Diabetes Care, 43, pp.S163~S182 (2020)
41. Czech MP, "Insulin action and resistance in obesity and type 2 diabetes", Nat Med, 23, pp.804~814 (2017)
42. Boucher J, "Insulin receptor signaling in normal and insulin-resistant states", Cold Spring Harb Perspect Biol, 6, pp.a009191~ (2014)
43. Choi SM, "Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway", Mol Cell Biol, 30, pp.5009~5020 (2010)
44. Kahn BB, "Obesity and insulin resistance", J Clin Investig, 106, pp.473~481 (2000)
45. Matthaei S, "Pathophysiology and pharmacological treatment of insulin resistance", Endocr Rev, 21, pp.585~618 (2000)
46. Kahn SE, "Mechanisms linking obesity to insulin resistance and type 2 diabetes", Nature, 444, pp.840~846 (2006)
47. Bonora E, "Insulin resistance as an independent risk factor for cardiovascular disease : clinical assessment and therapy approaches", Av Diabetol, 21, pp.255~261 (2005)
48. DeFronzo RA, "Glucose clamp technique : a method for quantifying insulin secretion and resistance", Am J Physiol, 237, pp.214~223 (1979)
49. Muniyappa R, "Current approaches for assessing insulin sensitivity and resistance in vivo : advantages, limitations, and appropriate usage", Am J Physiol Endocrinol Metab, 294, pp.15~26 (2008)
50. Arslanian SA, "Clamp techniques in paediatrics : what have we learned", Horm Res, 64, pp.16~24 (2005)
51. van der Aa MP, "Definition of insulin resistance affects prevalence rate in pediatric patients : a systematic review and call for consensus", J Pediatr Endocrinol Metab, 30, pp.123~131 (2017)
52. Gutch M, "Assessment of insulin sensitivity", resistance, 2015, pp.19, 160~164
53. Hwu CM, "Me asurements of insulin resistance in hypertension: where are we now?", J Human Hypertens, 21, pp.693~696 (2007)
54. Lee S, "Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice", Am J Physiol Endocrinol Metab, 294, pp.261~270 (2008)
55. Rasmussen-Torvik LJ, "Heritability and genetic correlations of insulin sensitivity measured by the euglycaemic clam", Diabet Med, 24, pp.1286~1289 (2007)
56. Keskin M, "Homeostasis model assessment is more reliable than the fasting glucose", insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents, 2005, pp.115, 500~503
57. Cutfield WS, "Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children", Pediatr Diabetes, 4, pp.119~125 (2003)
58. Wallace TM, "The assessment of insulin resistance in man", Diabet Med, 19, pp.527~534 (2002)
59. Gungor N, "Validation of surro gate est imates of insu lin s ensit iv ity and insulin secretion in children and adolescents", J Pediatr, 144, pp.47~55 (2004)
60. Giannini C, "The triglyceride-to-HDL cholesterol ratio : association with insulin resistance in obese youths of different ethnic backgrounds", Diabetes Care, 34, pp.1869~1874 (2011)
61. McAuley KA, "Diagnosing insulin resistance in the general population", Diabetes Care, 24, pp.460~464 (2001)
62. Jayagopal V, "the biological variation of sex hormonebinding globulin in type 2 diabetes: implications for sex hormone-binding globulin as a surrogate marker of insulin resistance", Diabetes Care, 27, pp.278~280 (2004)
63. Monzillo LU, "Evaluation of insulin sensitivity in clinical practice and in research settings", Nutr Rev, 61, pp.397~412 (2003)
64. Matsuda M, "Insulin sensitivity indices obtained from oral glucose tolerance testing : comparison with the euglycemic insulin clamp", Diabetes Care, 22, pp.1462~1470 (1999)
65. Cederholm J, "Insulin release and peripheral sensitivity at the oral glucose tolerance test", Diab Res Clin Pract, 10, pp.167~175 (1990)
66. Rossner SM, "HOMA-IR and QUICKI : decide on a general standard instead of making further comparisons", Acta Paediatr, 99, pp.1735~1740 (2010)
67. Rivera P, "A novel approach to childhood obesity : circulating chemokines and growth factors as biomarkers of insulin resistance", Pediatric Obesity, 14, pp.12473~ (2019)
68. Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance", J Clin Invest, 112, pp.1821~1830 (2003)
69. Rosa Mistica C. Ignacio, "Differential Chemokine Signature between Human Preadipocytes and Adipocytes", Immune Network, 16(3), pp.189~194 (2016), 대한면역학회[DOI]
70. da Silva CC, "Homeostatic model assessment of adiponectin (HOMAAdiponectin) as a surrogate measure of insulin resistance in adolescents: comparison with the hyperglycaemic clamp and homeostatic model assessment of insulin resistance", PLoS One, 14, pp.e0214081~ (2019)
71. Yadav A, "Role of leptin and adiponectin in insulin resistance", Clin Chim Acta, 417, pp.80~84 (2013)
72. Lee S, "Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity", Diabetes Care, 29, pp.51~56 (2006)
73. Weiss R, "Low adiponectin levels in adolescent obesity : a marker of increased intramyocellular lipid accumulation", J Clin Endocrinol Metab, 88, pp.2014~2018 (2003)
74. Vieira-Ribeiro SA, "The TyG index cutoff point and its association with body adiposity and lifestyle in children", J Pediatr, 95, pp.217~223 (2019)
75. Guerrero-Romero F, "Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults", Arch Med Res, 47, pp.382~387 (2016)
76. Kang B, "Triglycerides", glucose index is a useful surrogate marker of insulin resistance among adolescents, 2017, pp.41, 789~792
77. 문신제, "The Cut-off Values of Triglycerides and Glucose Index for Metabolic Syndrome in American and Korean Adolescents", Journal of Korean Medical Science, 32(3), pp.427~433 (2017), 대한의학회
78. Cerf ME, "Beta cell dysfunction and insulin resistance", Front Endocrinol (Lausanne), 4, pp.37~ (2013)
79. Ono H, "Molecular mechanisms of hypothalamic insulin resistance", Int J Mol Sci, 15, pp.1317~ (2019)
80. Chiasson JL, "Prevention of type 2diabetes : insulin resistance and beta-cell function", Diabetes, 53, pp.S34~S38 (2004)
81. Shanik MH, "Insulin resistance and hyperinsulinemia : is hyperinsulinemia the cart or the horse", Diabetes Care, 31, pp.S262~S268 (2008)
82. Parker VE, "Mechanistic insights into insulin resistance in the genetic era", Diabet Med, 28, pp.1476~1486 (2011)
83. Klotz LO, "Redox regulation of FoxO transcription factors", Redox Biol, 6, pp.51~72 (2015)
84. Ryder JW, "Skeletal muscle and insulin sensitivity : pathophysiological alterations", Front Biosci, 6, pp.D154~D163 (2001)
85. Gross DN, "The role of FoxO in the regulation of metabolism", Oncogene, 27, pp.2320~2336 (2008)
86. Titchenell PM, "Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production", Cell Metab, 23, pp.1154~1166 (2016)
87. Banks AS, "Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice", Cell Metab, 14, pp.587~597 (2011)
88. Corkey BE, "Banting lecture 2011 : hyperinsulinemia : cause or consequence", Diabetes, 61, pp.4~13 (2012)
89. Corkey BE, "Diabetes : have we got it all wrong? Insulin hypersecretion and food additives : cause of obesity and diabetes", Diabetes Care, 35, pp.2432~2437 (2012)
90. Kim MK, "Hyperinsulinemia in individuals with obesity : role of insulin clearance", Obesity (Silver Spring), 23, pp.2430~2434 (2015)
91. Agrawal NK, "Targeting inflammation in diabetes : newer therapeutic options", World J Diabetes, 5, pp.697~710 (2014)
92. Wang X, "Inflammatory markers and risk of type 2 diabetes : a systematic review and meta-analysis", Diabetes Care, 36, pp.166~175 (2013)
93. Reinehr T, "Inflammator y markers in children and adolescents with type 2 diabetes mellitus", Clin Chim Acta, 496, pp.100~107 (2019)

관련 논문AI추천